2 results
Approved WMOCompleted
The primary hypotheses in this study is that a cangrelor infusion will maintain target levels of platelet inhibition (> 60% inhibition) after discontinuation of a thienopyridine (clopidogrel or ticlopidine) in patients waiting for surgery.
BioXmark liquid fiducial to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial
To test the feasibility and accuracy of BioXmark fiducial markers for IGRT based rectal tumor boosting.